平安好医生与辉瑞中国达成合作持续探索“医药险患”融合路径_老虎社区_美港股上老虎

平安好医生与辉瑞中国达成合作持续探索“医药险患”融合路径

证券日报网07-09 21:47

本报讯(记者张文湘见习记者占健宇)近日，平安健康医疗科技有限公司(以下简称“平安好医生”)宣布与辉瑞投资有限公司(简称“辉瑞中国”)达成深度合作，双方将共同打造“医药险商业闭环”与“医药患全病程管理”双闭环体系，持续探索医、药、险、患融合路径。当前，随着公众健康需求不断升级，创新药物可及性、支付保障及院内外疾病管理协同等方面仍面临挑战。据了解，此次合作旨在通过整合双方优势资源，推动医疗服务、药品...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2650927491?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-07-09 21:47","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2650927491","market":"other","top_or_hot":-1,"title":"平安好医生与辉瑞中国达成合作 持续探索“医药险患”融合路径","media":"证券日报网","content":"<div>\n<p>本报讯(记者张文湘见习记者占健宇)近日，平安健康医疗科技有限公司(以下简称“平安好医生”)宣布与辉瑞投资有限公司(简称“辉瑞中国”)达成深度合作，双方将共同打造“医药险商业闭环”与“医药患全病程管理”双闭环体系，持续探索医、药、险、患融合路径。当前，随着公众健康需求不断升级，创新药物可及性、支付保障及院内外疾病管理协同等方面仍面临挑战。据了解，此次合作旨在通过整合双方优势资源，推动医疗服务、药品...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/relnews/hk/2026-07-09/doc-inihfpqx5264182.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>平安好医生与辉瑞中国达成合作 持续探索“医药险患”融合路径</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n平安好医生与辉瑞中国达成合作 持续探索“医药险患”融合路径\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-09 21:47 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/relnews/hk/2026-07-09/doc-inihfpqx5264182.shtml><strong>证券日报网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>本报讯(记者张文湘见习记者占健宇)近日，平安健康医疗科技有限公司(以下简称“平安好医生”)宣布与辉瑞投资有限公司(简称“辉瑞中国”)达成深度合作，双方将共同打造“医药险商业闭环”与“医药患全病程管理”双闭环体系，持续探索医、药、险、患融合路径。当前，随着公众健康需求不断升级，创新药物可及性、支付保障及院内外疾病管理协同等方面仍面临挑战。据了解，此次合作旨在通过整合双方优势资源，推动医疗服务、药品...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/relnews/hk/2026-07-09/doc-inihfpqx5264182.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1142","symbol_name":"互联网与直销零售","start_time":0,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-07-09/doc-inihfpqx5264182.shtml","article_id":"2650927491","we_media_id":null,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-07-09/doc-inihfpqx5264182.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2650927491","pubTimestamp":1783604820,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"本报讯 近日，平安健康医疗科技有限公司宣布与辉瑞投资有限公司达成深度合作，双方将共同打造“医药险商业闭环”与“医药患全病程管理”双闭环体系，持续探索医、药、险、患融合路径。据悉，双方还将持续围绕肿瘤、罕见病、疫苗及代谢健康等领域展开合作探索。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1142":"互联网与直销零售","LU0058720904.USD":"联博国际健康护理基金A","LU1894683264.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) ACC","BK1219":"保健护理服务","BK1617":"AI医疗","BK4007":"制药","SG9999001176.USD":"United Global Healthcare Acc USD","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1894683348.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) INC","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","BK1615":"港股-互联网","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","BK4581":"高盛持仓","BK4599":"减肥药","PFE":"辉瑞","SG9999002232.USD":"Allianz Global High Payout USD","BK1571":"互联网医疗","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","BK1515":"抗疫概念","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","SG9999002224.SGD":"Allianz Global High Payout SGD","LU1883839398.USD":"AMUNDI FUNDS INCOME OPPORTUNITIES \"A2\" (USD) ACC","BK4568":"美国抗疫概念","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU0306806265.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" ACC","OZEM":"Roundhill GLP-1 & Weight Loss ETF","LU0225771236.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (USD) INC MF","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","BK1247":"药品零售","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0225284248.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" ACC","IE00B3T34201.USD":"BNY MELLON GLOBAL EQUITY INCOME \"B\" (USD) INC","LU2596442595.SGD":"AMUNDI FUNDS INCOME OPPORTUNITIES \"A2\" (SGDHDG) INC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","01833":"平安好医生","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","LU0306807586.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" (USD) INC QF","BK4592":"伊斯兰概念","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","BK4588":"碎股","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","LU0122379950.USD":"贝莱德世界健康科学A2","LU0234572021.USD":"高盛美国核心股票组合Acc","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU0985481810.HKD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (HKD) INC M","IE000M9KFDE8.USD":"NEUBERGER BERMAN US LARGE CAP VALUE \"A\" (USD) ACC","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","LU0321505439.SGD":"Schroder ISF Global Dividend Maximiser A Acc SGD","BK4550":"红杉资本持仓","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD"},"translate_title":"Ping An Good Doctor and Pfizer China reach cooperation to continue to explore the integration path of \"medical risk\"","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01833":1.96,"PFE":1.92,"OZEM":0.6},"content_text":"本报讯(记者张文湘见习记者占健宇)近日，平安健康医疗科技有限公司(以下简称“平安好医生”)宣布与辉瑞投资有限公司(简称“辉瑞中国”)达成深度合作，双方将共同打造“医药险商业闭环”与“医药患全病程管理”双闭环体系，持续探索医、药、险、患融合路径。当前，随着公众健康需求不断升级，创新药物可及性、支付保障及院内外疾病管理协同等方面仍面临挑战。据了解，此次合作旨在通过整合双方优势资源，推动医疗服务、药品创新与支付保障更加紧密衔接，为用户提供更高质量、更可持续的健康管理解决方案。在“医药险商业闭环”层面，双方将围绕重点疾病领域探索单病种保险产品创新；在“医药患全病程管理闭环”层面，双方将共同打造覆盖疾病筛查、患者教育、规范诊疗、精准用药和长期随访的全周期服务体系，持续提升用户体验和健康获益。据悉，双方还将持续围绕肿瘤、罕见病、疫苗及代谢健康等领域展开合作探索。中国平安联席CEO兼平安好医生董事长郭晓涛表示，中国平安长期坚持“综合金融+医疗养老”战略布局，未来，中国平安将全方位支撑双闭环模式落地生根，助力全球优质创新药惠及国内广大群众；同时以智能化完善全周期健康管理体系，为行业提供高价值的综合医健解决方案。平安好医生CEO何明科表示，医药险深度融合是互联网医疗核心发展方向，未来平安好医生将持续对外输出可复制、可规模化的双闭环体系，赋能更多头部药企。\n\n\n海量资讯、精准解读，尽在新浪财经APP","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}